Tat, S. K., Pelletier, J., Lajeunesse, D., Fahmi, H., Lavigne, M., & Martel-Pelletier, J. (2008). The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor κB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells. Clin Exp Rheumatol.
Chicago-stil citatTat, Steeve Kwan, Jean-Pierre Pelletier, Daniel Lajeunesse, Hassan Fahmi, Martin Lavigne, och Johanne Martel-Pelletier. "The Differential Expression of Osteoprotegerin (OPG) and Receptor Activator of Nuclear Factor κB Ligand (RANKL) in Human Osteoarthritic Subchondral Bone Osteoblasts Is an Indicator of the Metabolic State of These Disease Cells." Clin Exp Rheumatol 2008.
MLA-referensTat, Steeve Kwan, et al. "The Differential Expression of Osteoprotegerin (OPG) and Receptor Activator of Nuclear Factor κB Ligand (RANKL) in Human Osteoarthritic Subchondral Bone Osteoblasts Is an Indicator of the Metabolic State of These Disease Cells." Clin Exp Rheumatol 2008.